Physician profile
Kenneth Baker
NPI 1871556084
$1,117.35
in general payments reported to CMS, 2019-2025
14 companies · $99.64 in 2025
The $99.64 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $113 · 2021: $123 · 2022: $75.15 · 2023: $202 · 2024: $348 · 2025: $99.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $649.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $183.92 | 2024 | Wegovy |
| Abbvie INC. | $174.76 | 2019-2024 | |
| Hologic Sales and Service, LLC | $172.38 | 2019-2023 | Acessa Provu System |
| Exact Sciences Corporation | $100.09 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $99.28 | 2019-2021 | |
| Astellas Pharma US INC | $88.75 | 2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $80.68 | 2019-2023 | |
| Exeltis, USA INC. | $73.63 | 2023-2025 | Slynd |
| Boston Scientific Corporation | $38.22 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $30.39 | 2019 | |
| Sumitomo Pharma America, INC. | $24.16 | 2023 | Gemtesa |
| Axonics, INC. | $19.26 | 2024 | Axonics |
| Organon LLC | $19.10 | 2021 | |
| Allergan, INC. | $12.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.